Literature DB >> 17638084

Epigenetic reprogramming and imprinting in origins of disease.

Wan-yee Tang1, Shuk-mei Ho.   

Abstract

The traditional view that gene and environment interactions control disease susceptibility can now be expanded to include epigenetic reprogramming as a key determinant of origins of human disease. Currently, epigenetics is defined as heritable changes in gene expression that do not alter DNA sequence but are mitotically and transgenerationally inheritable. Epigenetic reprogramming is the process by which an organism's genotype interacts with the environment to produce its phenotype and provides a framework for explaining individual variations and the uniqueness of cells, tissues, or organs despite identical genetic information. The main epigenetic mediators are histone modification, DNA methylation, and non-coding RNAs. They regulate crucial cellular functions such as genome stability, X-chromosome inactivation, gene imprinting, and reprogramming of non-imprinting genes, and work on developmental plasticity such that exposures to endogenous or exogenous factors during critical periods permanently alter the structure or function of specific organ systems. Developmental epigenetics is believed to establish "adaptive" phenotypes to meet the demands of the later-life environment. Resulting phenotypes that match predicted later-life demands will promote health, while a high degree of mismatch will impede adaptability to later-life challenges and elevate disease risk. The rapid introduction of synthetic chemicals, medical interventions, environmental pollutants, and lifestyle choices, may result in conflict with the programmed adaptive changes made during early development, and explain the alarming increases in some diseases. The recent identification of a significant number of epigenetically regulated genes in various model systems has prepared the field to take on the challenge of characterizing distinct epigenomes related to various diseases. Improvements in human health could then be redirected from curative care to personalized, preventive medicine based, in part, on epigenetic markings etched in the "margins" of one's genetic make-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638084      PMCID: PMC4056338          DOI: 10.1007/s11154-007-9042-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  92 in total

Review 1.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.

Authors:  Rudolf Jaenisch; Adrian Bird
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

2.  Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission.

Authors:  Vardhman K Rakyan; Suyinn Chong; Marnie E Champ; Peter C Cuthbert; Hugh D Morgan; Keith V K Luu; Emma Whitelaw
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 3.  From epigenesis to epigenetics: the case of C. H. Waddington.

Authors:  Linda Van Speybroeck
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

Review 4.  Metastable epialleles in mammals.

Authors:  Vardhman K Rakyan; Marnie E Blewitt; Riki Druker; Jost I Preis; Emma Whitelaw
Journal:  Trends Genet       Date:  2002-07       Impact factor: 11.639

5.  Long term low-dose arsenic exposure induces loss of DNA methylation.

Authors:  John F Reichard; Michael Schnekenburger; Alvaro Puga
Journal:  Biochem Biophys Res Commun       Date:  2006-11-10       Impact factor: 3.575

6.  A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry.

Authors:  Simonetta Friso; Sang-Woon Choi; Gregory G Dolnikowski; Jacob Selhub
Journal:  Anal Chem       Date:  2002-09-01       Impact factor: 6.986

7.  Genistein alters methylation patterns in mice.

Authors:  J Kevin Day; Andrew M Bauer; Charles DesBordes; Yi Zhuang; Byung-Eun Kim; Leslie G Newton; Vedika Nehra; Kara M Forsee; Ruth S MacDonald; Cynthia Besch-Williford; Tim Hui-Ming Huang; Dennis B Lubahn
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

8.  Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high doses.

Authors:  L C Alworth; K L Howdeshell; R L Ruhlen; J K Day; D B Lubahn; T H M Huang; C L Besch-Williford; F S vom Saal
Journal:  Toxicol Appl Pharmacol       Date:  2002-08-15       Impact factor: 4.219

9.  Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development.

Authors:  M Monk; M Boubelik; S Lehnert
Journal:  Development       Date:  1987-03       Impact factor: 6.868

10.  The prospective role of abnormal methyl metabolism in cadmium toxicity.

Authors:  Lionel A Poirier; Tatyana I Vlasova
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

View more
  83 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 2.  Environmental epigenetics and allergic diseases: recent advances.

Authors:  J S Kuriakose; R L Miller
Journal:  Clin Exp Allergy       Date:  2010-08-16       Impact factor: 5.018

Review 3.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

Review 4.  IBS: An epigenetic perspective.

Authors:  Timothy G Dinan; John Cryan; Fergus Shanahan; P W Napoleon Keeling; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

5.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

Review 6.  Developmental Programming, a Pathway to Disease.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso; Muraly Puttabyatappa
Journal:  Endocrinology       Date:  2016-02-09       Impact factor: 4.736

Review 7.  An overview of epigenetic assays.

Authors:  J Tyson DeAngelis; Woodrow J Farrington; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2007-10-18       Impact factor: 2.695

Review 8.  Developmental and Transmittable Origins of Obesity-Associated Health Disorders.

Authors:  Arin K Oestreich; Kelle H Moley
Journal:  Trends Genet       Date:  2017-04-21       Impact factor: 11.639

Review 9.  Developmental Programming of Ovarian Functions and Dysfunctions.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

10.  Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein.

Authors:  Wan-Yee Tang; Retha Newbold; Katerina Mardilovich; Wendy Jefferson; Robert Y S Cheng; Mario Medvedovic; Shuk-Mei Ho
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.